home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630712.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
2KB
|
39 lines
Document 0712
DOCN M9630712
TI Voluntary anonymous linked study of the prevalence of HIV infection and
hepatitis C among inmates in a Canadian federal penitentiary for women.
DT 9603
AU Ford PM; White C; Kaufmann H; MacTavish J; Pearson M; Ford S;
Sankar-Mistry P; Connop P; Department of Medicine, Queen's University,
Kingston, ON.
SO Can Med Assoc J. 1995 Dec 1;153(11):1605-9. Unique Identifier : AIDSLINE
MED/96088804
AB OBJECTIVE: To determine the seroprevalence of HIV infection and
hepatitis C among inmates of a federal penitentiary for women. DESIGN:
Voluntary, anonymous, linked, point-prevalence study involving testing
of blood samples for antibodies to HIV and hepatitis C virus.
PARTICIPANTS: All inmates of the multilevel security federal Prison for
Women, Kingston, Ont., who volunteered to participate in the study.
Inmates at this long-stay facility are from across Canada. OUTCOME
MEASURE: Seroprevalence rate among participants of antibodies to HIV and
hepatitis C virus. RESULTS: Of the 130 inmates available for study 113
(86.9%) agreed to donate a blood sample. One woman (0.9%) was HIV
positive; 45 (39.8%) were positive for hepatitis C antibody.
CONCLUSIONS: It is possible to obtain a high participation rate in a
voluntary, anonymous, linked point-prevalence study in a long-stay
penitentiary. The HIV seroprevalence rate of 0.9% is lower than that
found in studies in provincial (short-stay) prisons. However, the high
rate of antibodies to hepatitis C suggests a significant level of risk
behaviour, most likely injection drug use, and suggests the potential
for a rapid increase in the rate of HIV infection should the number of
newly admitted HIV-positive inmates who use injection drugs rise.
DE Adolescence Adult Canada/EPIDEMIOLOGY Comorbidity Female Hepatitis
C/BLOOD/COMPLICATIONS/*EPIDEMIOLOGY Human *HIV Seroprevalence Middle
Age Prevalence *Prisoners Residence Characteristics
Seroepidemiologic Methods Support, Non-U.S. Gov't Women's Health
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).